Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Eliminate the variability and uncertainty of primary cell-based assays
December 2016
SHARING OPTIONS:

Promega
 
Characterize your immune-modulating antibodies the best way possible. Our reporter bioassay platform uses standardized controls and reagents plus cells in a thaw-and-use format that eliminates the uncertainty of using primary cells. Use the PD-1/PD-L1 Immune Checkpoint Bioassay to measure the potency and stability of antibody candidates designed to block the PD-1/PD-L1 interaction and to measure antibody function throughout drug research and development.
 
Promega

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2017 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.